SoniVie announces advancements in its renal denervation program: REDUCED-1 pilot study results, radial access First-In-Human results, and FDA pivotal IDE approval of The THRIVE global study ...Middle East

SoniVie announces RDN pilot results, radial access FIH and FDA pivotal IDE approval, initiating the global THRIVE study in US, Europe and Israel TEL AVIV, Israel, July 24, 2024 /PRNewswire/ -- SoniVie, which has developed a novel proprietary Therapeutic Intra-Vascular Ultrasound System...

Hence then, the article about sonivie announces advancements in its renal denervation program reduced 1 pilot study results radial access first in human results and fda pivotal ide approval of the thrive global study was published today ( Wednesday 24/07/2024 - 02:45 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( SoniVie announces advancements in its renal denervation program: REDUCED-1 pilot study results, radial access First-In-Human results, and FDA pivotal IDE approval of The THRIVE global study )

Also on site :

• Contractor that cut back ancient oak in London park identified
• Jennifer Siebel Newsom’s Parenting Tips Include Dolls for Boys and Gender-Swapping Male Book Characters
• Myanmar’s coup leader elected president by pro-military parliament